GATA2 co-opts TGFβ1/SMAD4 oncogenic signaling and inherited variants at 6q22 to modulate prostate cancer progression.
Yang X, Zhang Q, Li S, Devarajan R, Luo B, Tan Z, Wang Z, Giannareas N, Wenta T, Ma W, Li Y, Yang Y, Manninen A, Wu S, Wei GH.
Yang X, et al. Among authors: manninen a.
J Exp Clin Cancer Res. 2023 Aug 8;42(1):198. doi: 10.1186/s13046-023-02745-7.
J Exp Clin Cancer Res. 2023.
PMID: 37550764
Free PMC article.